Log in
OTCMKTS:ESALY

Eisai Stock Forecast, Price & News

$74.00
-0.70 (-0.94 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$73.58
Now: $74.00▼
$74.19
50-Day Range
$73.69
MA: $81.43▼
$114.50
52-Week Range
$54.00
Now: $74.00▼
$125.00
Volume4,863 shs
Average Volume4,564 shs
Market Capitalization$21.95 billion
P/E Ratio18.55
Dividend Yield1.74%
Beta0.51
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which includes third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.
Read More
Eisai logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.25 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ESALY
Previous Symbol
CUSIPN/A
CIK948406
Webwww.eisai.co.jp
Phone813-3817-3700
Employees10,998

Debt

Debt-to-Equity Ratio0.08
Current Ratio2.16
Quick Ratio1.86

Price-To-Earnings

Trailing P/E Ratio18.55
Forward P/E Ratio33.94
P/E GrowthN/A

Sales & Book Value

Annual Sales$6.40 billion
Price / Sales3.43
Cash Flow$3.12 per share
Price / Cash Flow23.74
Book Value$21.80 per share
Price / Book3.39

Profitability

EPS (Most Recent Fiscal Year)$3.91
Net Income$1.12 billion
Net Margins17.61%
Return on Equity18.37%
Return on Assets11.95%

Miscellaneous

Outstanding Shares296,567,000
Market Cap$21.95 billion
Next Earnings Date1/29/2021 (Estimated)
OptionableNot Optionable
$74.00
-0.70 (-0.94 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ESALY News and Ratings via Email

Sign-up to receive the latest news and ratings for ESALY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eisai (OTCMKTS:ESALY) Frequently Asked Questions

How has Eisai's stock been impacted by COVID-19?

Eisai's stock was trading at $72.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ESALY stock has increased by 1.5% and is now trading at $74.00.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Eisai?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eisai.

What stocks does MarketBeat like better than Eisai?

Wall Street analysts have given Eisai a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eisai wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Eisai's next earnings date?

Eisai is scheduled to release its next quarterly earnings announcement on Friday, January 29th 2021.
View our earnings forecast for Eisai.

How were Eisai's earnings last quarter?

Eisai Co., Ltd. (OTCMKTS:ESALY) issued its earnings results on Thursday, November, 5th. The company reported $0.05 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.32 by $0.27. Eisai had a net margin of 17.61% and a return on equity of 18.37%.
View Eisai's earnings history.

What guidance has Eisai issued on next quarter's earnings?

Eisai issued an update on its FY 2020 IntraDay earnings guidance on Thursday, November, 5th. The company provided earnings per share guidance of 2.22-2.22 for the period. The company issued revenue guidance of $6.848-6.848 billion.

Are investors shorting Eisai?

Eisai saw a decrease in short interest during the month of October. As of October 30th, there was short interest totaling 900 shares, a decrease of 75.0% from the October 15th total of 3,600 shares. Based on an average daily trading volume, of 7,300 shares, the short-interest ratio is currently 0.1 days.
View Eisai's Short Interest.

Who are some of Eisai's key competitors?

Some companies that are related to Eisai include Iberdrola (IBDRY), Airbus (EADSY), Schneider Electric S.E. (SBGSY), L'Air Liquide (AIQUY), Recruit (RCRRF), Daikin Industries,Ltd. (DKILY), KDDI (KDDIY), Shin-Etsu Chemical (SHECY), Vinci (VCISY), Atlas Copco (ATLKY), Deutsche Post (DPSGY), Bayerische Motoren Werke Aktiengesellschaft (BAMXF), Oriental Land (OLCLY), HOYA (HOCPY) and Pjsc Lukoil (LUKOY).
View all competitors.

Who are Eisai's key executives?

Eisai's management team includes the following people:
  • Mr. Haruo Naito, CEO, Representative Corp. Officer & Director (Age 73)
  • Mr. Gary Hendler, Sr. VP & Pres of EMEA Region (Age 54)
  • Dr. Lynn D. Kramer, VP & Chief Clinical Officer - Neurology Bus. Group (Age 70)
  • Ms. Yanhui Feng, Sr. VP
  • Mr. Nadeem Sarwar, Pres
  • Mr. Ryohei Yanagi, Exec. VP & CFO (Age 58)
  • Ms. Sayoko Sasaki, Chief IR Officer & VP (Age 52)
  • Mr. Mitsuaki Tanaka, Chief Compliance Officer, Internal Control, Chief Information Security Officer & VP
  • Mr. Yasushi Okada, Representative Corp. Officer, COO, Industry Affairs, China Bus. & Data Integrity (Age 62)
  • Mr. Edward Stewart Geary, Sr. VP & Global Safety Officer (Age 58)

What is Eisai's stock symbol?

Eisai trades on the OTCMKTS under the ticker symbol "ESALY."

How do I buy shares of Eisai?

Shares of ESALY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eisai's stock price today?

One share of ESALY stock can currently be purchased for approximately $74.00.

How big of a company is Eisai?

Eisai has a market capitalization of $21.95 billion and generates $6.40 billion in revenue each year. The company earns $1.12 billion in net income (profit) each year or $3.91 on an earnings per share basis. Eisai employs 10,998 workers across the globe.

What is Eisai's official website?

The official website for Eisai is www.eisai.co.jp.

How can I contact Eisai?

Eisai's mailing address is 4-6-10 Koishikawa Bunkyo-ku, Tokyo M0, 112-8088. The company can be reached via phone at 813-3817-3700.

This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.